
Tesamorelin + Ipamorelin — targeted visceral-fat reduction.
A protocol pairing Tesamorelin — the GHRH analog with the most direct clinical record for visceral-fat reduction — with Ipamorelin to sustain the GH pulse. Tesamorelin pushes the GH-axis toward visceral adipose tissue specifically; Ipamorelin maintains elevated GH over time for a synergistic effect on body composition.
Who it's for: Adults whose metabolic picture includes visceral adiposity — often as an adjunct to GLP-1 therapy or hormone optimization.
VITALIZE pairs 2 compounds:
Tesamorelin (synthetic GHRH analog)
Stable GHRH analog, FDA-approved for HIV-associated lipodystrophy and the most extensively studied GHRH analog for visceral adipose tissue reduction.
Used for
Ipamorelin (selective GH secretagogue)
Selective ghrelin-receptor agonist that adds a clean GH pulse without raising cortisol or prolactin, sustaining the GH elevation that complements Tesamorelin.
Used for
The following reflects areas of interest commonly reported by members and studied in the clinical literature. Results depend on individual health status, labs, and physician-directed care. Nothing below constitutes a treatment claim.
Tesamorelin has the most direct clinical record in the GHRH-analog class for VAT reduction — distinct from subcutaneous fat loss.
Often paired with GLP-1 protocols for members whose metabolic picture includes visceral adiposity rather than just total body weight.
Tesamorelin pushes the GH-axis while Ipamorelin sustains the pulse — a combination greater than either peptide alone.
VITALIZE is prescribed and monitored against labs. The Halftime Baseline panel ($249, separate onboarding deliverable) covers the relevant markers below.
VITALIZE is most commonly chosen by members whose primary intent is one of:
Available at every tier
The Halftime Baseline lab panel ($249) is a separate onboarding deliverable, available at any tier.
Join the waitlistLaunching July 1, 2026
All prescriptions require physician evaluation. Compounded medications are not FDA-approved. Individual results vary. This is not medical advice.